Introduction: Due to highly active antiretroviral therapy (HAART), HIV-1 infection has evolved from a lethal to a chronic disease. As such, health-related quality of life (HRQoL) has become an important outcome variable. The purpose of this study was to identify socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL among people living with HIV (PLHIV). Methods: This study was conducted between 1 January and 31 December 2012 at the AIDS Reference Centre of Ghent University Hospital, a tertiary care referral centre in Belgium. Validated self-report questionnaires were administered to collect sociodemographic data, to assess HRQoL (Medical Outcomes Study-HIV), depressive symptoms (Beck Depression Inventory-II) and adherence to HAART (Short Medication Adherence Questionnaire) and to screen for neurocognitive dysfunction. Results: A total of 237 people participated, among whom 187 (78.9%) were male. Mean age was 45.8910.7 years and 144 (63.7%, 144/226) participants were homosexual. Median physical and mental health score (PHS, MHS) were 55.6 (IQR 48.2Á 60.6) and 52.0 (IQR 44.2Á57.9), respectively. Multivariable regression analysis revealed that incapacity to work, depressive symptoms, neurocognitive complaints (NCCs), dissatisfaction with the patientÁphysician relationship and non-adherence were all negatively associated with HRQoL. Conclusions: Socio-economic (work status), behavioural (adherence) and (neuro)psychological (depressive symptoms, NCCs) determinants independently impact HRQoL among this cohort of PLHIV. Clinical parameters (viral load, CD4 cell count) were not independently associated with HRQoL.
Introduction
In Belgium, 12,600 people living with HIV (PLHIV) are medically followed, and there is a stable incidence rate of three new diagnoses per day [1] . Highly active antiretroviral therapy (HAART) therapy is reimbursed by health insurance, and more than 80% of the people on HAART have an undetectable viral load [2] . Worldwide, similar significant improvements in virological control through HAART emerge, and HIV has developed into a chronic disease with reasonable life expectancy [3] . Hence, the prevalence of PLHIV still increases [4] . As a result, concerns about lifelong medication use as well as physical and mental consequences of a chronic illness became important outcome indicators. In HIV treatment decisions, the impact on health-related quality of life (HRQoL) is a particular point of interest [5] . Maximizing HRQoL is a key goal in HIV care and, therefore, it is necessary to identify which factors influence HRQoL. Changing or managing these factors by means of targeted interventions should be the focus of healthcare managers and policy makers.
Studies investigating determinants of HRQoL found associations with clinical [6Á9], socio-economic [10Á12], psychological [13Á16] and behavioural [17Á20] parameters. Those studies mostly examined a specific and limited set of parameters within their field of interest. However, few studies [21Á23] evaluated parameters from different categories simultaneously and none of them included neuropsychological parameters. As such, the possible distinctive influence of neurocognitive problems on HRQoL remains unclear.
This study is the first to investigate HRQoL in Belgium, and the first to incorporate neuropsychological parameters in a broad and detailed set of possible determinants of HRQoL.
Methods Setting
The study was conducted at the AIDS Reference Centre of Ghent University Hospital (GUH), one of nine tertiary care referral centres in Belgium involved in the medical treatment and emotional and social support for PLHIV. One thousand three-hundred PLHIV are currently followed by a multidisciplinary team of physicians, (social) nurses, psychologists and psychiatrists. The collaborating AIDS Reference Laboratory is responsible for HIV diagnosis (serology, viral load, resistance, genotyping) and data collection of blood values.
Participants
To obtain a representative sample of the HIV population seen in the ARC, all PLHIV consulting the ARC during the study period were eligible to participate. There were no constraints concerning age, time since diagnosis, treatment or other variables. Treating physicians recruited participants during a routine patient visit via informed consent, available in Dutch, French and English. The study was approved by the Ethics Committee of GUH and recruitment of participants started on 1 January 2012.
Instruments
Patients were asked to fill in a self-developed and validated self-report questionnaire and to participate in a short interview with a nurse. Socio-demographic and socio-economic questions, as well as three validated instruments (Medical Outcomes Study-HIV Á MOS-HIV, Short Medication Adherence Questionnaire Á SMAQ and Beck Depression Inventory-II Á BDI-II) were incorporated in the bundle.
To evaluate HRQoL, the MOS-HIV [24] was used. This instrument contains 35 items, which lead to 11 subscale scores between 0 and 100 (health perceptions, pain, physical functioning, social functioning, role functioning, mental functioning, energy, cognitive functioning, health distress, quality of life and health transition). Two final scores are then calculated: the physical health score (PHS) and the mental health score (MHS).
In addition, participants were asked to fill in the six-item SMAQ [25] and the 21-item BDI-II [26] . Presence of depressive symptoms in people with chronic illnesses is defined as a score of 17 or more on the BDI-II [27] .
In a short interview with a nurse, the patients answered three questions to screen for the presence of neurocognitive complaints (NCCs) [28] . Memory, planning and attention problems were surveyed. One or more ''yes'' answers are indicative for NCCs.
Clinical data were obtained through the electronic patient file. At the time of assessment, the vast majority (92.0%, 218/ 237) was receiving HAART, and viral load and CD4 cell count were B 40 copies/ml and 500 cells/ml in 74.3% (176/237) and 59.9% (142/237) of participants, respectively.
Analyses
Depressive symptoms were observed in 22.3% (51/229) of the participants and 86 participants (36.3%) had NCCs.
In this sample, there is an underrepresentation of black PLHIV as compared to the PLHIV seen in the centre (10% vs. 24%) and of people with foreign origin as compared to the total Belgian cohort (10% vs. 49%). Male-to-female ratio is higher than the ratio in the total Belgian cohort (4 vs. 1.7). Mean age in the study sample (45.8 years) is higher than mean age of PLHIV seen in the centre (44.1 years) and mean age of the total Belgian cohort (43.1 years).
Population characteristics, also disaggregated by gender, are available as Supplementary file.
Quality of life
Median PHS and MHS are 55.6 (IQR 48.2Á60.6) and 52.0 (IQR 44.2Á57.9), respectively. PHS is significantly higher than MHS (pB0.001, Table 1 ) and there is a significant correlation between them (0.644; p B0.01). The median scores on the subscales, for men and women, are shown in Table 1 . Table 2 shows the results of the bivariate analysis. A lower PHS and MHS is seen in PLHIV who are female (p B0.001 and 0.006), not working (seeking work B0.001 and 0.048, househusband/housewife 0.021 and 0.015, invalid both B0.001), living alone (p 00.003 and B0.001) and having an income Bt1.500 (both p B0.001). Lower PHS and MHS are also associated with shorter time since diagnosis (p 00.017 and 0.040), the presence of depressive symptoms (both p B0.001), NCCs (both pB0.001), less satisfaction with relationship with physician (p 00.049 and 0.004), dissatisfaction with social support (both p B0.001), dissatisfaction with sex life (both p B0.001) and poor adherence (both p B0.001). Black ethnicity (p 00.030) and dissatisfaction with information received about medication (p 00.010) are associated with lower PHS, whereas not being married (divorced p 00.006, single B0.001) and drug use (p00.021) are associated with lower MHS (Table 2) .
Multivariable linear regression analysis shows that the presence of depressive symptoms, NCCs, work incapacity, satisfaction with the patientÁphysician relationship and nonadherence are independently associated with both poor PHS and MHS. Seeking work and being a househusband/housewife negatively influence PHS. Dissatisfaction with sex life is associated with lower MHS (Table 3) .
Discussion
PHS and MHS of the MOS-HIV in this cohort of PLHIV are high and comparable to those found in HIV patients studied in other countries [10,21,29Á31] . Scores on the subscales of the MOS-HIV are even comparable to those found in a general healthy population, except for a lower score for mental health [32] . The good clinical status of our cohort and the high representation of white gay men might be a potential explanation. In people with other chronic diseases such as chronic fatigue syndrome or rheumatoid arthritis, substantially lower HRQoL scores have been reported [32, 33] . It seems that HIV does not interfere with daily life to the same extent as these other chronic diseases.
Determinants associated with a lower HRQoL in this study are the presence of depressive symptoms, NCCs, working situation, satisfaction with the relationship with the physician, adherence and satisfaction with sex life.
It is well known that depressive symptoms negatively impact perceived HRQoL [16, 23, 34, 35] . In this study, depressive symptoms were independently associated with both poor MHS and PHS. Moreover, depressive symptoms interfere with all domains as measured by the subscales of the MOS-HIV (except health transition), which emphasizes their considerable impact. Systematic and periodic screening for depression, as well as an appropriate treatment if necessary, is imperative to intervene in this prominent problem.
NCCs were found to be independently associated with lower PHS, MHS and lower subscale scores (except health transition). Neurocognitive impairment has already been shown to be a predictor of poor HRQoL [36] and to be significantly associated with lower scores on all HRQoL subscales [37] . This might be explained by difficulties in coping with daily activities such as stocking, managing their money, planning appointments and so on, which potentially lead to frustration and a loss of independence [36] . Medical professionals, family members and PLHIV themselves should be vigilant for these signs. Screening and prevention of HIV-associated neurocognitive disorder should become more familiar in HIV care to determine effective treatment strategies (exclude neurotoxicity if possible, treating co-morbidity, etc.) [38] .
We could not, however, confirm the presence of NCCs by a neurocognitive testing battery, but it was previously observed that patient-reported measures of neurocognitive functioning and results on objective neurocognitive testing correlate significantly [37] .
Several studies report that employed PLHIV tend to have better HRQoL [10,12,39Á41] . Employment has an important role in the daily life of people. It provides structure, a social support network, role identity and meaning [40] . Physical functioning, role functioning, social functioning, pain, mental health and health distress were found to be significantly affected by disability. Differences in physical health as compared to employed people were also observed in job seekers. They have lower scores in physical-, role-, and social functioning and energy.
The exact association between employment and HRQoL remains unproven. This is possibly a bi-directional relationship [10, 12] . PLHIV with good HRQoL can choose to work (selection hypothesis), or work can be a source of wellbeing (causation hypothesis) [10] . Working should be encouraged and therefore possible internal or external barriers should be addressed [42] . PLHIV could be advised by peers, medical professionals and HR-and labour legislation experts about their rights and about practical concerns and discomforts. Our research group, in collaboration with the Flemish expertise centre on sexual health, currently gathers experiences from PLHIV at the workplace. This is a first step in developing a framework for employers and employees to inform them and to guide them through HIV at the workplace.
The importance of a good patientÁphysician relationship is emphasized by its contribution to both physical and mental health. It was shown that a good and trustful patientÁ physician relationship contributes to a good adherence [43, 44] and to an undetectable viral load [44] . Mental health improves by the feeling of ''being treated as a person'' and trust in the physician [44, 45] . The perception of empathy and a good knowledge about HIV seem to be predictive for satisfaction about the patientÁphysician relationship [46] . Physicians should be aware of this and invest in their relationship with PLHIV.
Furthermore, adherence itself influences HRQoL. Differences between adherent versus non-adherent participants are seen in all subscales of the MOS-HIV, which corresponds with the overall conclusion of the review on this topic by Geocze, Mucci, De Marco, Nogueira-Martins and Cicero [20] . Out of 12 studies, 10 showed a positive association between adherence and HRQoL. A causal relationship was, however, not clear. Adherence to ART could lead to better HRQoL, considering the protective role of ART in disease progression and mortality. However, ART frequently causes serious side effects (e.g. nausea, diarrhoea, lipodystrophy), which of course negatively influence HRQoL. Some PLHIV may therefore feel the tendency to stop adhering to ART in an attempt to re-establish their HRQoL. Another possibility could be that adherence and HRQoL have overlapping determinants. However, it is evident that adherence remains a highly important goal and moreover, interventions to improve adherence could have additional HRQoL benefits. PLHIV who are satisfied about their sex life have a higher MHS than those who are not. In the literature, studies addressing this relationship are scarce. Most research discusses sexual dysfunction rather than sexual satisfaction [47] . However, there is evidence that a good sex life contributes to good HRQoL in the general population [48] and that experiencing sexual problems is associated with poorer quality of life in gay men [49] . In our study, dissatisfaction with sex life is associated with significant lower scores on all subscales of the MOS-HIV except health transition. Apparently, multiple domains of HRQoL are influenced by this presently understudied outcome measure. We recommend to break the taboo about sexual problems and to take these complaints seriously. They can be the expression of multiple stressors: for example, troubles in the current relationship, loneliness, trauma and physical causes. Accurate identification of the cause(s) should lead to the right treatment approach [50] .
There are several study limitations that need to be addressed. The number of participants is limited. Nevertheless, good predictive models for HRQoL were achieved and the number is considered as adequate given the great detail in our research. A second limitation is the self-report of depressive symptoms and NCCs. Formal testing by a psychiatrist or neuropsychologist was not done. Because of the cross-sectional design, we were not able to determine causal relationships. Furthermore, taking into account the non-normal PHS and MHS, linear regression analysis reveals less correct models than median regression analysis would do. Our study results can also not be generalized to the population of PLHIV in Belgium, as our sample included an . In fact, in this study, physical and mental health were found to be influenced by mainly the same parameters. Behind these limitations, some strengths of this pilot study should be considered. To the best of our knowledge, this study is the first to investigate HRQoL among PLHIV in Belgium. Moreover, in addition to clinical variables, whose relationship with HRQoL has been the focus of a limited number of studies [6, 52, 53] , many other (socio-economic, behavioural and psychological) variables were analyzed and were found to be associated with HRQoL. Calling more attention to non-clinical parameters in HIV care seems to be a relevant approach.
Conclusions
PHS is high in this cohort of PLHIV. Not the clinical, but socioeconomic (working), behavioural (adherence, sex life) and (neuro)psychological (depressive symptoms, NCCs) variables significantly influence HRQoL, as well as the perceived quality of the patientÁphysician relationship. Future research should focus on interventions to improve HRQoL, in hospital settings (supporting adherence, screening for and treating depression and neurocognitive problems, improving patientÁphysician relationship) and abroad (framework for HIV at the workplace, promoting sexual health).
